Age Related Macular Degeneration study: Text Message Reminder vs Health Worker Visit
Official title Strategies for Improving Linkage-to-Care After Eye Disease Screening
ClinicalTrials.gov ID: NCT06943599
What this study is testing
- What it's testing
- The study wants to see which method best gets people to visit the eye hospital within 21 days after being referred.
- Who it's for
- People who were screened for age‑related macular degeneration, diabetic retinopathy, or glaucoma and were referred to the hospital.
- What's involved
- Participants will be randomly assigned to receive either text message reminders, reminders from health workers, or no reminder. They will then be asked to go to the eye hospital for a follow‑up visit.
- Time commitment
- The study lasts 21 days after the screening, during which participants must attend the hospital visit if they are reminded.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- \- Participant of the VIEW II study referred to the eye hospital at their eye screening visit.
You likely can't join if
- Residence in an area without reliable mobile connectivity
The study team makes the final eligibility decision.
Where it is enrolling
- San Francisco, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at San Francisco, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.